New rules may constrain docs' ability to treat chronic pain

New rules may constrain docs' ability to treat chronic pain

(HealthDay)—New laws and regulations designed to limit the use of prescription narcotics may further constrain doctors' ability to treat patients, according to an article published online May 30 in Medical Economics.

Physicians and public health and pain management experts are concerned that laws and regulations may represent another constraint on doctors' ability to treat patients in the way they think best. Although the huge death toll from opioids needs to be reduced, physicians are concerned about how to provide adequate chronic for patients.

The most recent action aimed at reducing opioid use was a Centers for Medicare and Medicaid Services rule denying coverage for Medicare Part D beneficiaries whose total daily opioid dose exceeds 90 morphine milligram equivalents. In addition, for patients receiving opioids for the first time, coverage is limited to seven days, with no exceptions. Physicians have complained that the policy is not consistent with the U.S. Centers for Disease Control and Prevention guideline on opioid prescribing. In addition, physicians cannot exercise their clinical judgment about the appropriate course of therapy for specific . Obstacles to prescribing opioids have also come from payers, with insurance companies limiting opioid coverage. Some specialists believe the solution to the crisis lies in devoting more resources to helping addicts rather than via outside interference.

Primary care physicians can still prescribe medications; records should be properly documented, including the patient's medical history and physical exam, the rationale for prescribing opioids, and discussion of the risks and benefits.

More information: More Information

Journal information: Medical Economics

Copyright © 2018 HealthDay. All rights reserved.

Citation: New rules may constrain docs' ability to treat chronic pain (2018, June 29) retrieved 28 September 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Coverage policies compared for back pain medications


Feedback to editors